SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010578
Filing Date
2021-08-05
Accepted
2021-08-05 16:29:41
Documents
49
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nxtc-20210630x10q.htm   iXBRL 10-Q 1176835
2 EX-31.1 nxtc-20210630xex31d1.htm EX-31.1 12901
3 EX-31.2 nxtc-20210630xex31d2.htm EX-31.2 12697
4 EX-32.1 nxtc-20210630xex32d1.htm EX-32.1 12241
  Complete submission text file 0001558370-21-010578.txt   4565021

Data Files

Seq Description Document Type Size
5 EX-101.SCH nxtc-20210630.xsd EX-101.SCH 24346
6 EX-101.CAL nxtc-20210630_cal.xml EX-101.CAL 34229
7 EX-101.DEF nxtc-20210630_def.xml EX-101.DEF 74664
8 EX-101.LAB nxtc-20210630_lab.xml EX-101.LAB 285838
9 EX-101.PRE nxtc-20210630_pre.xml EX-101.PRE 187236
10 EXTRACTED XBRL INSTANCE DOCUMENT nxtc-20210630x10q_htm.xml XML 863852
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38905 | Film No.: 211148775
SIC: 2834 Pharmaceutical Preparations